SCHEMBL5211567

SCHEMBL5211567

CCCc1c(OCCCCOc2cccc(N3CC(=O)SC3=O)c2)ccc2c(CCc3ccccc3)coc12

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 17/20 0.43
PPARG P37231 16/20 0.43
PPARD Q03181 16/20 0.43
PDE5A O76074 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5208436 0.88 PPARA (0.41) PPARAPPARGPPARDPDE5A
SCHEMBL5208484 0.87 PPARD (0.39) PPARAPPARGPPARDPDE5A
SCHEMBL5211391 0.86 PPARG (0.40) PPARAPPARGPPARD
SCHEMBL5204448 0.84 PPARG (0.40) PPARAPPARGPPARD
SCHEMBL7671701 0.84 PPARA (0.43) PPARAPPARGPPARDPDE5A
SCHEMBL7665347 0.84 PPARA (0.43) PPARAPPARGPPARDPDE5A
SCHEMBL5205501 0.78 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL5211565 0.77 PPARG (0.61) PPARAPPARGPPARD
SCHEMBL7454425 0.76 PPARG (0.43) PPARAPPARGPPARDPDE5A
SCHEMBL7464894 0.76 PPARG (0.42) PPARAPPARGPPARDPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040102-B1 ARYLTHIAZOLIDINEDIONE DERIVATIVES MERCK & CO INC (US) 2007-01-24 EP disclosed
US-6399640-B1 ANTIDIABETIC AGENTS; ANTICHOLESTEROL AGENTS MERCK & CO., INC. 2002-06-04 US disclosed
US-6200998-B1 PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS; ANTICHOLESTEROL, ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. 2001-03-13 US disclosed
US-6008237-A POTENT AGONISTS OF PEROXIDSOME PROLIFERATOR ACTIVATED RECEPTOR; FOR CONTROLLING OR PREVENTING OF DIABETES, HYPERGLYCEMIA, HYPERLIPIDEMIA, HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS, OBESITY, VASCULAR RESTENOSIS MERCK & CO., INC. (US) 1999-12-28 US disclosed